Newsoara Biopharma Co., Ltd.
Clinical trials sponsored by Newsoara Biopharma Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug HY8931 put to the test in healthy volunteers Results expected Sep 2026 (estimated)
- New drug HY6725 enters first human safety tests Results expected Mar 2027 (estimated)
-
New drug HY6725 enters first human safety tests
Knowledge-focused Recruiting nowThis early-phase trial is testing an experimental drug called HY6725 in 74 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo as a single injection or two injections one month apart. The study does not aim to treat…
Phase 1 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New drug HY8931 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study tests whether a new drug, HY8931, is safe and how the body processes it. Sixty healthy adults aged 18 to 45 will receive either the drug or a placebo. Participants will be monitored for up to 90 days after dosing.
Phase 1 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC